Standard BioTools Inc. (NASDAQ:LAB) Q3 2022 Results Conference Call November 8, 2022 5:00 PM ET
Company Participants
Peter DeNardo - Investor Relations
Michael Egholm - Chief Executive Officer and President
Vikram Jog - Chief Financial Officer
Operator
Hello, and welcome to the Standard BioTools Inc. Third Quarter 2022 Financial Results Conference Call. As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Peter DeNardo, Investor Relations. Thank you, Mr. DeNardo. You may begin.
Peter DeNardo
Thank you, operator. Good afternoon, everyone. Welcome to Standard BioTools third quarter 2022 earnings conference call. At the close of the market today, Standard BioTools released its financial results for the quarter ended September 30, 2022.
During this call, we will review our results and provide commentary on our financial and operational performance, market trends and strategic initiatives. Presenting for Standard BioTools today will be Michael Egholm PhD, Chief Executive Officer and President; and Vikram Jog, our CFO.
During the call, we will make forward-looking statements about events and circumstances that have not yet occurred, including plans and projections for our business, future financial results and market trends and opportunities. These statements are subject to substantial risks and uncertainties that may cause actual events or results to differ materially from current expectations. The forward-looking statements in this call are based on information currently available to us and we disclaim any obligation to update these statements, except as may be required by law.
During the call, we will also present some financial information on a non-GAAP basis. We encourage you to carefully consider our results under GAAP as well as our supplemental non-GAAP information and the reconciliation between these presentations, which are disclosed in the table accompanying our earnings release. Please note that management will be referring to a slide presentation, including updated supplemental financial information within the webcast today, and this presentation is also posted on our website.
I would also like to note that the company will not be hosting a Q&A session following prepared remarks during today's conference call.
I will now turn the call over to Michael Egholm, our Chief Executive Officer and President. Michael?
Michael Egholm
Good afternoon, and welcome to Standard BioTools Third Quarter 2022 Conference Call and the first full quarter with our new executive leadership team in place.
The Standard BioTools tools corporate transformation of this company begins with stabilizing what we now call our core commercial business, which will assess holistically on the basis of instrument growth, consumables and service revenue.